Lavipharm Fair Value
0K
The fair market value of 0KDJ.L stock is 0.05 EUR. Relative to the market price of 0 EUR Lavipharm is overvalued by 94%
Eyestock's quantitative valuation approach is based on the method of estimating historical multipliers. To determine whether a stock is undervalued, we compare its current price to our estimated of fair value. The more undervalued a stock is, the more investment is profitable.
Fair Relative Value
Lavipharm Valuation
The fair value level of 0.05 EUR can be considered as an effective entry point for long-term investors to start investing in 0KDJ.L stock. For a more in-depth assessment, we provide a minimum value that can be used to increase a stock position and a maximum one that can be used to reduce it.
Price chart is not available
Current market price
Market price:
0KDJ.L stock is greatly overvalued
It means the current price may concern as a High Risk Entry Point
Lavipharm SA Stock Valuation Calculator
How do we value a stock?
As fair value, we use the product of the median Price-to-earnings ratios at the end of each reporting period for the last 5 years and earnings per share for the last 12 months. By analogy with the fair value, we calculate the maximum and minimum ones using the corresponding P/E extremums.
1
Maximum P/E over 5 years
77.29
2
Median P/E over 5 years
6.72
3
Minimum P/E over 5 years
2.23
4
Earning per share (last 12 months)
0.01 EUR
Maximum value
1
x
4
=
0.53 EUR
Fair value
2
x
4
=
0.05 EUR
Minimum value
3
x
4
=
0.02 EUR
Lavipharm SA price metrics
0.7
Annual return (geometric mean)
70.3
Risk (standard deviation) of returns
β
1.4
Beta (volatility compared to market)